These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11839678)

  • 1. Arsenic trioxide cytotoxicity in steroid and chemotherapy-resistant myeloma cell lines: enhancement of apoptosis by manipulation of cellular redox state.
    Gartenhaus RB; Prachand SN; Paniaqua M; Li Y; Gordon LI
    Clin Cancer Res; 2002 Feb; 8(2):566-72. PubMed ID: 11839678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system.
    Lösler S; Schlief S; Kneifel C; Thiel E; Schrezenmeier H; Rojewski MT
    Ann Hematol; 2009 Nov; 88(11):1047-58. PubMed ID: 19301004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imexon-induced apoptosis in multiple myeloma tumor cells is caspase-8 dependent.
    Evens AM; Prachand S; Shi B; Paniaqua M; Gordon LI; Gartenhaus RB
    Clin Cancer Res; 2004 Feb; 10(4):1481-91. PubMed ID: 14977852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
    Zhu XH; Shen YL; Jing YK; Cai X; Jia PM; Huang Y; Tang W; Shi GY; Sun YP; Dai J; Wang ZY; Chen SJ; Zhang TD; Waxman S; Chen Z; Chen GQ
    J Natl Cancer Inst; 1999 May; 91(9):772-8. PubMed ID: 10328107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Arsenic trioxide combined with buthionine sulfoximine enhances apoptosis in multidrug-resistant human leukemia K562/ADM cells in vitro].
    Wang T; Ma LM; Zhang HP; Wang HW; Yang LH; Qiao ZH
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):188-91. PubMed ID: 18756933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis.
    Kitamura K; Minami Y; Yamamoto K; Akao Y; Kiyoi H; Saito H; Naoe T
    Leukemia; 2000 Oct; 14(10):1743-50. PubMed ID: 11021749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line.
    Matulis SM; Morales AA; Yehiayan L; Croutch C; Gutman D; Cai Y; Lee KP; Boise LH
    Mol Cancer Ther; 2009 May; 8(5):1197-206. PubMed ID: 19417148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
    Kito M; Akao Y; Ohishi N; Yagi K; Nozawa Y
    Biochem Biophys Res Commun; 2002 Mar; 291(4):861-7. PubMed ID: 11866444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3.
    Hu XM; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):47-58. PubMed ID: 12750841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine.
    Wu XX; Ogawa O; Kakehi Y
    Int J Oncol; 2004 Jun; 24(6):1489-97. PubMed ID: 15138592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buthionine sulfoximine enhancement of arsenic trioxide-induced apoptosis in leukemia and lymphoma cells is mediated via activation of c-Jun NH2-terminal kinase and up-regulation of death receptors.
    Chen D; Chan R; Waxman S; Jing Y
    Cancer Res; 2006 Dec; 66(23):11416-23. PubMed ID: 17145888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic trioxide as a novel anticancer agent against human transitional carcinoma--characterizing its apoptotic pathway.
    Pu YS; Hour TC; Chen J; Huang CY; Guan JY; Lu SH
    Anticancer Drugs; 2002 Mar; 13(3):293-300. PubMed ID: 11984073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic trioxide inhibits growth of human multiple myeloma cells in the bone marrow microenvironment.
    Hayashi T; Hideshima T; Akiyama M; Richardson P; Schlossman RL; Chauhan D; Munshi NC; Waxman S; Anderson KC
    Mol Cancer Ther; 2002 Aug; 1(10):851-60. PubMed ID: 12492118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells.
    Davison K; Mann KK; Waxman S; Miller WH
    Blood; 2004 May; 103(9):3496-502. PubMed ID: 14701702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine.
    Maeda H; Hori S; Ohizumi H; Segawa T; Kakehi Y; Ogawa O; Kakizuka A
    Cell Death Differ; 2004 Jul; 11(7):737-46. PubMed ID: 15002036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by arsenic trioxide of human hepatoma cell growth.
    Oketani M; Kohara K; Tuvdendorj D; Ishitsuka K; Komorizono Y; Ishibashi K; Arima T
    Cancer Lett; 2002 Sep; 183(2):147-53. PubMed ID: 12065089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of all-trans-retinoic acid and arsenic trioxide on growth inhibition and apoptosis in human hepatoma, breast cancer, and lung cancer cells in vitro.
    Lin LM; Li BX; Xiao JB; Lin DH; Yang BF
    World J Gastroenterol; 2005 Sep; 11(36):5633-7. PubMed ID: 16237756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic trioxide induces multiple myeloma cell apoptosis via disruption of mitochondrial transmembrane potentials and activation of caspase-3.
    Jia P; Chen G; Huang X; Cai X; Yang J; Wang L; Zhou Y; Shen Y; Zhou L; Yu Y; Chen S; Zhang X; Wang Z
    Chin Med J (Engl); 2001 Jan; 114(1):19-24. PubMed ID: 11779429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells.
    Grad JM; Bahlis NJ; Reis I; Oshiro MM; Dalton WS; Boise LH
    Blood; 2001 Aug; 98(3):805-13. PubMed ID: 11468182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic trioxide-induced death of neuroblastoma cells involves activation of Bax and does not require p53.
    Karlsson J; Øra I; Pörn-Ares I; Påhlman S
    Clin Cancer Res; 2004 May; 10(9):3179-88. PubMed ID: 15131059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.